Moreover, both tumor and stromal cells from tiplaxtinin/gemcitabine/anti-PD1–treated mice showed reduced proliferation and increased apoptosis as evidenced by Ki67 and TUNEL assay, respectively (Fig. 6, F to H, and fig. The gene discussed is PDCD1; the disease is neoplasm.